Skip to content
DraconiticResearch
Search Sources API
174,684 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Imaging therapeutic response at brain neuroimmune interfaces in women with systemic lupus erythematosus

Abstract

PurposeSystemic lupus erythematosus (SLE) frequently affects the central nervous system, likely via neuroimmune interfaces; how these interfaces respond longitudinally to standard therapy remains unclear. This study aimed to clarify these therapeutic dynamics.MethodsThis retrospective longitudinal study included 63 women with SLE who had brain MRI at baseline and after standard therapy. Enlarged perivascular spaces (ePVS), choroid plexus (CP), and gray matter (GM) volumes were segmented from 3D T1-weighted images; the diffusion tensor imaging along the perivascular space (DTI-ALPS) index was computed from DTI scans. Paired t-tests compared baseline and post-therapy values. Patients were grouped into neuropsychiatric SLE (NPSLE) and non-NPSLE groups, and longitudinal deltas compared. Spearman correlations assessed associations of MRI changes with clinical measures.ResultsAfter standard therapy, all 63 patients showed clinical improvement (decreased SLEDAI-2K, increased MoCA scores). Left DTI-ALPS index increased (T = -2.475, PFDR = 0.048), and bilateral CP volumes decreased (left: T = 2.432, PFDR = 0.048; right: T = 3.330, PFDR = 0.006). ePVS volumes remained unchanged. No significant correlations emerged between MRI changes and clinical scores, and improvement did not differ between NPSLE and non-NPSLE subgroups.ConclusionsLongitudinal MRI identified measurable alterations in Neuroimmune Interfaces in women with SLE, particularly the DTI-ALPS index and CP volume. These changes correlate with clinical improvement and serve as supplementary imaging biomarkers for assessing disease activity, independent of neuropsychiatric involvement.

Related

  1. Regulatory T cell dysfunction and therapeutic advances in rheumatoid arthritis, psoriasis, vitiligo, and systemic lupus erythematosus
    Yanyang Liang, Haiyan Feng, Ying Wang +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref
  2. Diminished ovarian reserve in systemic lupus erythematosus: clinical, immunological, viral, and therapeutic determinants in a 24-month prospective study
    Margherita Rizzo, Silvia Beltrami, Francesca Ruffilli +9
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCPMC
  3. Immunological cross-talk between periodontitis and systemic lupus erythematosus: the role of T–B cell dysregulation in the shared pathogenic network
    Weiwen Hu, Jianxiong Wang, Jingjing Tong +7
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Mosaic KRAS variants in childhood-onset systemic lupus erythematosus.
    Hitoshi Irabu, Madoka Nishimura, Fumiaki Sakura +16
    Journal of human immunityPeer-reviewedCC BYFull textImmunologyGeneral medicineEurope PMCDOAJ
  5. Thrombotic microangiopathy in a patient with systemic lupus erythematosus and systemic sclerosis overlap syndrome: a case report and review of the literature
    Ahmad Al-Riyalat, Tawfiq Barqawi, Laith Sorour +3
    Journal of Rare DiseasesPeer-reviewedCC BYFull textImmunologyDOAJ
BibTeX
@article{liu2026imaging,
  title = {{Imaging therapeutic response at brain neuroimmune interfaces in women with systemic lupus erythematosus}},
  author = {Huiyang Liu and Bailing Tian and Huanhuan Li and Zhen Sun and Zhenxing Li and Pingting Yang and Guoguang Fan and Hu Liu},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = nov,
  doi = {10.3389/fimmu.2026.1959975},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1959975},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Imaging therapeutic response at brain neuroimmune interfaces in women with systemic lupus erythematosus
AU  - Huiyang Liu
AU  - Bailing Tian
AU  - Huanhuan Li
AU  - Zhen Sun
AU  - Zhenxing Li
AU  - Pingting Yang
AU  - Guoguang Fan
AU  - Hu Liu
PY  - 2026
DA  - 2026/11/04
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1959975
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1959975
AB  - PurposeSystemic lupus erythematosus (SLE) frequently affects the central nervous system, likely via neuroimmune interfaces; how these interfaces respond longitudinally to standard therapy remains unclear. This study aimed to clarify these therapeutic dynamics.MethodsThis retrospective longitudinal study included 63 women with SLE who had brain MRI at baseline and after standard therapy. Enlarged perivascular spaces (ePVS), choroid plexus (CP), and gray matter (GM) volumes were segmented from 3D T1-weighted images; the diffusion tensor imaging along the perivascular space (DTI-ALPS) index was computed from DTI scans. Paired t-tests compared baseline and post-therapy values. Patients were grouped into neuropsychiatric SLE (NPSLE) and non-NPSLE groups, and longitudinal deltas compared. Spearman correlations assessed associations of MRI changes with clinical measures.ResultsAfter standard therapy, all 63 patients showed clinical improvement (decreased SLEDAI-2K, increased MoCA scores). Left DTI-ALPS index increased (T = -2.475, PFDR = 0.048), and bilateral CP volumes decreased (left: T = 2.432, PFDR = 0.048; right: T = 3.330, PFDR = 0.006). ePVS volumes remained unchanged. No significant correlations emerged between MRI changes and clinical scores, and improvement did not differ between NPSLE and non-NPSLE subgroups.ConclusionsLongitudinal MRI identified measurable alterations in Neuroimmune Interfaces in women with SLE, particularly the DTI-ALPS index and CP volume. These changes correlate with clinical improvement and serve as supplementary imaging biomarkers for assessing disease activity, independent of neuropsychiatric involvement.
SN  - 1664-3224
ER  -